
pmid: 24163747
pmc: PMC3804883
Radiation Oncology technology has continued to advance at a rapid rate and is bringing significant benefits to patients. This review outlines some of the advances in technology and radiotherapy treatment of thoracic cancers including brachytherapy, stereotactic radiotherapy, tomotherapy and intensity modulated radiotherapy. The importance of functional imaging with PET and management of movement are highlighted. Most of the discussion relates to non-small cell lung cancer but management of mesothelioma and small cell lung cancer are also covered. This technology has substantial benefits to patients in terms of decreasing toxicity both in the short and longer term.
Stage, advances, Radiotherapy, thoracic, review, Positron-Emission-Tomography, Chemoradiation, 2740 Pulmonary and Respiratory Medicine, Pet/ct, technology, Combination, Malignant Pleural Mesothelioma, Cell Lung-Cancer, Modulated Radiation-Therapy, Helical Tomotherapy, Pneumonitis
Stage, advances, Radiotherapy, thoracic, review, Positron-Emission-Tomography, Chemoradiation, 2740 Pulmonary and Respiratory Medicine, Pet/ct, technology, Combination, Malignant Pleural Mesothelioma, Cell Lung-Cancer, Modulated Radiation-Therapy, Helical Tomotherapy, Pneumonitis
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
